Forte Biosciences, Inc.
NASDAQ:FBRXBiotechnology
Healthcare
$76.99 +1.71%
+$0.30 today
- Market cap
- $1.58B
- Beta
- 2.87
- P/E (TTM)
- -42.1
- EPS (TTM)
- -$0.43
52W Low $9.10High $35.80
Volume 0.00M
Average 0.30M
Balance Sheet
Inspect the capital base behind the business.
Assets
$82.78M
FY 2025 · Annual
+34.5% YoYLiabilities
$21.79M
FY 2025 · Annual
+139.9% YoYEquity
$60.99M
FY 2025 · Annual
+16.2% YoYBalance Sheet
USD
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $58.2M |
| Receivables | $655.0K |
| Other Current | $6.2M |
| Total Current Assets | $65.1M |
| PP&E (Net) | $110.0K |
| Other Non-current | $2.0M |
| Total Non-current Assets | $2.1M |
| Total Assets | $67.2M |
Analysis
Selected assets total $67.2M for Latest. The largest visible component is Cash & Equivalents at $58.2M, about 86.6% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| SC 14D9/A | SC 14D9/A filing | Aug 21, 2026 | |
| SC TO-T/A | SC TO-T/A filing | Aug 19, 2026 | |
| SC 14D9/A | SC 14D9/A filing | Aug 19, 2026 | |
| SC 13G/A | SC 13G/A filing | Aug 14, 2026 | |
| SC 13G/A | SC 13G/A filing | Aug 13, 2026 |
How much cash does FBRX have?
Forte Biosciences, Inc. (FBRX) reported $76.96M in cash and equivalents in fiscal 2025.
How much debt does FBRX carry?
Forte Biosciences, Inc. (FBRX) reported $0.00 of total debt, with net debt of -$76.96M.
Continue the stock analysis
Jump to another research area for this company.